Docebo Reports Strong Q4 & FY2025 Results, Raises 2026 Guidance, and Reaffirms $60M Share Buyback Commitment

summarizeSummary

Docebo Inc. announced strong Q4 and FY2025 financial results with significant growth in revenue and net income, issued positive guidance for 2026, and reaffirmed its commitment to a $60 million share buyback by waiving a market price condition.

check_boxKey Events

• Strong Q4 and FY2025 Financial Performance

  Docebo reported a 11% increase in Q4 2025 total revenue to $63.0 million and a 11.9% increase for the full fiscal year to $242.7 million. Net income surged by 125.5% in Q4 to $26.9 million and by 40.3% for the full year to $37.5 million. Adjusted EBITDA also saw substantial growth, up 40.2% in Q4 and 30.6% for the full year.

• Positive 2026 Financial Guidance Issued

  The company provided optimistic guidance for Q1 2026, projecting total revenue between $63.5 million and $63.7 million, and Adjusted EBITDA between $10.3 million and $10.5 million. For the full fiscal year 2026, Docebo expects total revenue between $267.5 million and $269.5 million and Adjusted EBITDA between $52.5 million and $54.5 million.

• Commitment to $60M Share Buyback Reaffirmed

  Docebo announced it has waived the 'share price condition' related to its previously announced substantial issuer bid to repurchase up to $60 million of its common shares at $20.40 per share. This decision underscores the company's belief that the current trading price does not fully reflect its value, despite a market price decrease exceeding 10% since February 1, 2026. The offer expires March 10, 2026.

auto_awesomeAnalysis

Docebo Inc. delivered robust financial performance for Q4 and the full fiscal year 2025, significantly exceeding prior year figures across key metrics like net income and Adjusted EBITDA. The company also provided optimistic financial guidance for Q1 and the full fiscal year 2026, signaling continued growth. A notable development is the company's unwavering commitment to its substantial issuer bid, waiving a condition related to market price decline. This demonstrates strong management confidence in the company's intrinsic value and future prospects, despite recent market fluctuations. Investors should view this as a strong signal of operational health and strategic conviction.